Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. WEAV
WEAV logo

WEAV Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Weave Communications Inc (WEAV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.410
1 Day change
-2.70%
52 Week Range
12.190
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Weave Communications Inc (WEAV) is not a strong buy for a beginner, long-term investor at this time. The stock shows limited positive momentum, with bearish technical indicators, declining financial performance, and no significant positive catalysts. While analysts maintain a positive outlook, the stock's near-term risks outweigh its potential for long-term growth.

Technical Analysis

The MACD is positive and expanding, suggesting mild bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a lack of strong upward trend. Key resistance levels are close to the current price, limiting immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest a bullish sentiment in the options market, but the overall volume and activity are low, indicating limited conviction.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • Analysts maintain a Buy/Overweight rating, citing 17% YoY revenue growth, strong location additions, and AI-driven growth potential. Gross margin improved slightly YoY.

Neutral/Negative Catalysts

  • Net income and EPS have significantly declined YoY, reflecting poor profitability. Analysts have lowered price targets, and the stock is expected to decline in the short term (-7.97% in the next week, -7.05% in the next month). No significant hedge fund or insider activity, and no recent news or congress trading data.

Financial Performance

In Q4 2025, revenue grew 17.05% YoY to $63.4M, but net income dropped 72.46% YoY to -$1.85M. EPS fell 77.78% YoY to -$0.02. Gross margin improved slightly to 72.66%, but overall profitability remains a concern.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets (e.g., from $12 to $8-$10) but maintain Buy/Overweight ratings. They highlight AI and specialty medical as future growth drivers but note challenges in SMB software and the need for consistent profitability improvements.

Wall Street analysts forecast WEAV stock price to rise
4 Analyst Rating
Wall Street analysts forecast WEAV stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 5.560
sliders
Low
8
Averages
10.25
High
12
Current: 5.560
sliders
Low
8
Averages
10.25
High
12
Stifel
J. Parker Lane
Buy
downgrade
$11 -> $9
AI Analysis
2026-02-20
Reason
Stifel
J. Parker Lane
Price Target
$11 -> $9
AI Analysis
2026-02-20
downgrade
Buy
Reason
Stifel analyst J. Parker Lane lowered the firm's price target on Weave to $9 from $11 and keeps a Buy rating on the shares.
Piper Sandler
Overweight -> NULL
downgrade
$12 -> $8
2026-02-20
Reason
Piper Sandler
Price Target
$12 -> $8
2026-02-20
downgrade
Overweight -> NULL
Reason
Piper Sandler lowered the firm's price target on Weave to $8 from $12 and keeps an Overweight rating on the shares. The firm notes the company posted another quarter of 17% year-over-year growth, driven by payments, strong location additions, and the recent TrueLark acquisition. FY26 top-line growth guidance of 14.8% year-over-year came in roughly in-line with consensus expectations and implies a deceleration from the 17.0% growth in FY25, while operating income guidance implies 190 bps of operating margin expansion in the coming year. Looking ahead, Piper expects AI and specialty medical to be the biggest growth drivers in FY26.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for WEAV
Unlock Now

People Also Watch